ARCOSA INC (ACA) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ACA - US0396531008 - Common Stock
112.98 USD
+2.14 (+1.93%)
112.98 USD
0 (0%)
Overall ACA gets a fundamental rating of 5 out of 10. We evaluated ACA against 55 industry peers in the Construction & Engineering industry. ACA has an average financial health and profitability rating. ACA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ACA had positive earnings in the past year.
In the past year ACA had a positive cash flow from operations.
Each year in the past 5 years ACA has been profitable.
In the past 5 years ACA always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of ACA (2.94%) is comparable to the rest of the industry.
ACA has a worse Return On Equity (5.75%) than 60.00% of its industry peers.
The Return On Invested Capital of ACA (4.99%) is comparable to the rest of the industry.
ACA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is significantly below the industry average of 17.87%.
The last Return On Invested Capital (4.99%) for ACA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROIC | 4.99% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
ACA has a Profit Margin of 5.25%. This is in the better half of the industry: ACA outperforms 63.64% of its industry peers.
In the last couple of years the Profit Margin of ACA has declined.
The Operating Margin of ACA (10.27%) is better than 72.73% of its industry peers.
In the last couple of years the Operating Margin of ACA has declined.
ACA's Gross Margin of 21.61% is fine compared to the rest of the industry. ACA outperforms 61.82% of its industry peers.
In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ACA has more shares outstanding than it did 1 year ago.
ACA has more shares outstanding than it did 5 years ago.
ACA has a worse debt/assets ratio than last year.
2.2 Solvency
ACA has an Altman-Z score of 2.49. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
ACA has a Altman-Z score (2.49) which is in line with its industry peers.
ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.03, ACA is doing good in the industry, outperforming 61.82% of the companies in the same industry.
ACA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ACA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, ACA perfoms like the industry average, outperforming 58.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 2.49 |
ROIC/WACC0.51
WACC9.75%
2.3 Liquidity
A Current Ratio of 2.02 indicates that ACA has no problem at all paying its short term obligations.
The Current ratio of ACA (2.02) is better than 87.27% of its industry peers.
ACA has a Quick Ratio of 1.30. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ACA (1.30) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
ACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.03%, which is quite good.
The Earnings Per Share has been growing slightly by 5.16% on average over the past years.
ACA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.96%.
Measured over the past years, ACA shows a quite strong growth in Revenue. The Revenue has been growing by 8.15% on average per year.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
ACA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.53% yearly.
Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 7.41% on average per year.
EPS Next Y41.21%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue Next Year10.81%
Revenue Next 2Y8.38%
Revenue Next 3Y7.41%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 29.89, which means the current valuation is very expensive for ACA.
Based on the Price/Earnings ratio, ACA is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.76, ACA is valued at the same level.
The Price/Forward Earnings ratio is 23.18, which indicates a rather expensive current valuation of ACA.
Based on the Price/Forward Earnings ratio, ACA is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.96, ACA is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.89 | ||
| Fwd PE | 23.18 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACA is valued a bit cheaper than the industry average as 78.18% of the companies are valued more expensively.
ACA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACA is cheaper than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.61 | ||
| EV/EBITDA | 13.35 |
4.3 Compensation for Growth
ACA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACA's earnings are expected to grow with 22.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)5.79
EPS Next 2Y27.26%
EPS Next 3Y22.53%
5. Dividend
5.1 Amount
With a yearly dividend of 0.19%, ACA is not a good candidate for dividend investing.
ACA's Dividend Yield is a higher than the industry average which is at 1.65.
Compared to an average S&P500 Dividend Yield of 2.31, ACA's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
5.2 History
The dividend of ACA decreases each year by -0.48%.
ACA has been paying a dividend for over 5 years, so it has already some track record.
ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
112.98
+2.14 (+1.93%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners94.79%
Inst Owner Change-4.44%
Ins Owners1.8%
Ins Owner Change-2%
Market Cap5.54B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target122.23 (8.19%)
Short Float %2.25%
Short Ratio4.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)3.3%
PT rev (3m)3.3%
EPS NQ rev (1m)2.28%
EPS NQ rev (3m)3.23%
EPS NY rev (1m)3.78%
EPS NY rev (3m)5.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.89 | ||
| Fwd PE | 23.18 | ||
| P/S | 1.96 | ||
| P/FCF | 17.61 | ||
| P/OCF | 11.81 | ||
| P/B | 2.14 | ||
| P/tB | 6.03 | ||
| EV/EBITDA | 13.35 |
EPS(TTM)3.78
EY3.35%
EPS(NY)4.87
Fwd EY4.31%
FCF(TTM)6.41
FCFY5.68%
OCF(TTM)9.57
OCFY8.47%
SpS57.76
BVpS52.7
TBVpS18.72
PEG (NY)0.73
PEG (5Y)5.79
Graham Number66.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROCE | 6.5% | ||
| ROIC | 4.99% | ||
| ROICexc | 5.24% | ||
| ROICexgc | 8.62% | ||
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% | ||
| FCFM | 11.11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 3.04 | ||
| Cap/Depr | 68.36% | ||
| Cap/Sales | 5.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.74% | ||
| Profit Quality | 211.71% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 2.49 |
F-Score5
WACC9.75%
ROIC/WACC0.51
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y41.21%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.81%
Revenue Next 2Y8.38%
Revenue Next 3Y7.41%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.94%
EBIT Next 3Y39.06%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
What is the valuation status for ACA stock?
ChartMill assigns a valuation rating of 5 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
Can you provide the profitability details for ARCOSA INC?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARCOSA INC (ACA) stock?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 29.89 and the Price/Book (PB) ratio is 2.14.
What is the expected EPS growth for ARCOSA INC (ACA) stock?
The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 41.21% in the next year.